Furthermore, PSMA imaging provides information about metastatic sites and spread, which opens a window for other targeted therapies, such as radiation therapy or even surgery for reducing tumor burden or preventing severe functional limitations, such as bone fractures. This evidence concerns the gene FOLH1 and neoplasm.